As RNA therapeutics and vaccine markets rapidly expand, biopharma teams are searching for scalable, automation‑ready RNA purification solutions that can keep pace with growing demand. Therapeutic developers, CROs, and biomarker discovery groups are all accelerating RNA‑seq and high‑throughput screening workflows, yet RNA extraction remains one of the most persistent bottlenecks.
Zymo Research’s Quick‑RNA™ 96 kit is built for this new era of scale, involving more flexible automation, fewer manual transfer steps and lower reagent costs than competitors. It empowers RNA‑based therapeutic discovery and manufacturing with a workflow that delivers consistent, reproducible RNA across large studies. It enables biopharma labs to scale purification without disrupting existing processes, reducing downstream delays and eliminating the headaches caused by variability at high throughput. With the Quick‑RNA 96 kit, labs benefit from a workflow where speed and scalability go hand-in-hand.
The hidden time costs of scaling up
As sample volumes rise in therapeutic development pipelines, the limitations of traditional extraction workflows become impossible to ignore. What works for 8 or 24 samples breaks down at 96 or 384, creating friction across entire programs.
- Manual column handling grows exponentially: each additional sample adds another set of manual steps, increasing labour and introducing inconsistency, a major issue for regulated environments and parallel assays.
- Batch processing limits add friction: spin column formats or limited capacity instruments force staggered runs, interrupting end to end workflows such as biomarker discovery or RNA seq library prep.
- Spin times that compound into hours of lost productivity: a few minutes per spin doesn’t seem significant until it’s multiplied across dozens of plates, multiple technicians, and multiple workflows.
For biopharma teams under pressure to deliver faster insights, these recurring delays create downstream bottlenecks in QC, decision‑making, and assay completion.
Designed for scaled throughput and short hands-on time
The Quick‑RNA 96 kit is intentionally designed to support high‑throughput bioprocessing without adding workflow complexity. Its rapid bind-wash-elute chemistry is optimised for:
- Vacuum manifolds
- Centrifugation
- Automation-friendly liquid handling
By enabling true parallel processing, biopharma teams can process full plates simultaneously rather than in batches, dramatically reducing hands-on time and enabling continuous sample movement through pipelines.
For labs scaling RNA purification for therapeutic screening, viral RNA analysis, or RNA seq prep, this translates to:
- Faster turnaround times
- Consistent run to run performance
- Lower labour costs and fewer manual interventions
Automation readiness also means teams can scale without reinventing infrastructure or retraining technicians.
Simplified, plate-based workflows reduce cumulative delays
As biopharma groups scale, reproducibility becomes a non negotiable requirement. Variability in RNA purity or yield can derail high throughput screens, invalidate assay runs, or force costly repeat extractions.
The Quick RNA 96 format reduces these risks by minimising:
- Manual pipetting steps
- Plate transfers
- Opportunities for cross contamination
- Well to well inconsistency
By reducing manual touchpoints, labs achieve the consistent performance required for regulatory documentation, downstream analytics, and large scale decision making.
The compounding impact on downstream workflows
Speed in biopharma isn’t just about the extraction step, it’s also about everything that comes after it. Faster, predictable RNA purification accelerates entire workflows, enabling:
- Earlier QC: data becomes available sooner, accelerating decision-making.
- Uninterrupted library prep: no idle personnel or instruments waiting for RNA to be ready.
- Better instrument utilisation: qPCR and NGS platforms stay productive.
- Higher overall throughput: labs can process more samples per day without stretching resources.
RNA labs need solutions that scale without sacrificing reproducibility or disrupting established workflows. Zymo’s Quick RNA 96 kit offers a streamlined, automation ready platform that removes longstanding bottlenecks in RNA purification.
For teams driving RNA therapeutics, vaccine development, biomarker discovery, or high throughput sequencing, the result is more samples processed, fewer delays, and more confidence in every downstream decision.
If you are ready to experience the speed and scalability of Zymo’s Quick-RNA 96 kit, request a free sample or contact our team to learn more.